Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
Weight-Loss Care Trends: Certifications, Mental Health, and the Push for Oral GLP-1s: Certifications: Despite 81% reporting prescribing any medications for weight loss or a weight loss benefit in the past year, 67% of those surveyed report not having any Obesity Treatment Certification, such as the American Board of Obesity Medicine or European Association Study of Obesity Medicine
Looking ahead, with breakthroughs in novel molecular designs, oral formulations, small molecule drugs, and dual-target drugs pushing the boundaries of GLP-1 drug innovation, the market is expected to continue to grow.
95% CI, 0.38 to 1.16
doi:10.1093/ps/82.12.1932 Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I (2012) Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
US$ 23.45
US$ 29.63
US$ 29.93
US$ 29.91
US$ 22.71
US$ 20.11
US$ 20.49
US$ 26.59
US$ 21.05
US$ 21.67
US$ 25.62
US$ 24.99
